Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Dragonboat Biopharmaceutical Company Limited

Clinical trials sponsored by Dragonboat Biopharmaceutical Company Limited, explained in plain language.

Not yet recruiting 1

New drug trial aims to slow scarring lung disease

Disease control Not yet recruiting

This study is testing whether an experimental drug called BC006 can help control idiopathic pulmonary fibrosis (IPF), a serious lung-scarring disease. About 96 people with IPF will receive either BC006 or a placebo for 24 weeks to see if it safely slows the decline in lung functi…

Phase: PHASE2 • Sponsor: Dragonboat Biopharmaceutical Company Limited • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC